Arindrarto, Wibowo Borràs, Daniel M de Groen, Ruben A L van den Berg, Redmar R Locher, Irene J van Diessen, Saskia A M E van der Holst, Rosalie van der Meijden, Edith D Honders, M Willy de Leeuw, Rick H
...
Published in
Leukemia
Acute myeloid leukemia (AML) is caused by genetic aberrations that also govern the prognosis of patients and guide risk-adapted and targeted therapy. Genetic aberrations in AML are structurally diverse and currently detected by different diagnostic assays. This study sought to establish whole transcriptome RNA sequencing as single, comprehensive, a...
Ector, Geneviève I C G Visser, Otto Westerweel, Peter E Janssen, Jeroen J W M Blijlevens, Nicole M A Dinmohamed, Avinash G
Published in
Leukemia
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Herold, Tobias Rothenberg-Thurley, Maja Grunwald, Victoria V Janke, Hanna Goerlich, Dennis Sauerland, Maria C Konstandin, Nikola P Dufour, Annika Schneider, Stephanie Neusser, Michaela
...
Published in
Leukemia
The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk stratification of acute myeloid leukemia have been widely adopted, but have not yet been validated in large cohorts of AML patients. We studied 1116 newly diagnosed AML patients (age range, 18-86 years) who had received induction chemotherapy. Among 771 patients not select...
Ho, Matthew Patel, Ashish Goh, Chia Yin Moscvin, Maria Zhang, Li Bianchi, Giada
Published in
Leukemia
Multiple myeloma (MM) is a highly heterogenous disease that exists along a continuous disease spectrum starting with premalignant conditions monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) that inevitably precede MM. Over the past two decades, significant progress has been made in the genetic characte...
Hurwitz, Stephanie N Jung, Seul K Kurre, Peter
Published in
Leukemia
Hematopoietic stem and progenitor cells (HSPCs) are responsible for lifelong maintenance of hematopoiesis through self-renewal and differentiation into mature blood cell lineages. Traditional models hold that HSPCs guard homeostatic function and adapt to regenerative demand by integrating cell-autonomous, intrinsic programs with extrinsic cues from...
Pan, Jing Tan, Yue Deng, Biping Tong, Chunrong Hua, Lin Ling, Zhuojun Song, Weiliang Xu, Jinlong Duan, Jiajia Wang, Zelin
...
Published in
Leukemia
Siegel, David S Schiller, Gary J Samaras, Christy Sebag, Michael Berdeja, Jesus Ganguly, Siddhartha Matous, Jeffrey Song, Kevin Seet, Christopher S Talamo, Giampaolo
...
Published in
Leukemia
Patients with multiple myeloma who have relapsed after or become refractory to lenalidomide in early treatment lines represent a clinically important population in need of effective therapies. The safety and efficacy of pomalidomide, low-dose dexamethasone, and daratumumab was evaluated in lenalidomide-pretreated patients with relapsed or refractor...
Dun, Matthew D Mannan, Abdul Rigby, Callum J Butler, Stephen Toop, Hamish D Beck, Dominik Connerty, Patrick Sillar, Jonathan Kahl, Richard G S Duchatel, Ryan J
...
Published in
Leukemia
Jensen, Patrizia Carlet, Michela Schlenk, Richard F Weber, Andrea Kress, Jana Brunner, Ines Słabicki, Mikołaj Grill, Gregor Weisemann, Simon Cheng, Ya-Yun
...
Published in
Leukemia
Acute myeloid leukemia (AML) is an aggressive disease for which only few targeted therapies are available. Using high-throughput RNA interference (RNAi) screening in AML cell lines, we identified LIM kinase 1 (LIMK1) as a potential novel target for AML treatment. High LIMK1 expression was significantly correlated with shorter survival of AML patien...
Loontiens, Siebe Vanhauwaert, Suzanne Depestel, Lisa Dewyn, Givani Van Loocke, Wouter Moore, Finola E Garcia, Elaine G Batchelor, Lance Borga, Chiara Squiban, Barbara
...
Published in
Leukemia